{"transactions":[{"id":851876,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T20:06:32.000Z","date":"2026-03-09","kind":"sale","planned":true,"acquired":false,"shares":5087,"price":74.13,"value":377099.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $72.94 to $74.76. The price reported above reflects the weighted average sales price."}],"balance_after":51946,"source":{"system":"sec-edgar","filing":"0001946439-26-000010","document":"wk-form4_1773173188.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000010/wk-form4_1773173188.xml","form_type":"4"}},{"id":851875,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-03-10T20:06:32.000Z","date":"2026-03-06","kind":"sale","planned":true,"acquired":false,"shares":1485,"price":75,"value":111375.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025."}],"balance_after":57033,"source":{"system":"sec-edgar","filing":"0001946439-26-000010","document":"wk-form4_1773173188.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000010/wk-form4_1773173188.xml","form_type":"4"}},{"id":875170,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-03-02T22:57:59.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":1555,"price":73.9,"value":114914.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,040 shares of restricted stock, the grant of which was previously reported."}],"balance_after":58518,"source":{"system":"sec-edgar","filing":"0001946439-26-000008","document":"wk-form4_1772492277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000008/wk-form4_1772492277.xml","form_type":"4"}},{"id":875169,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-03-02T22:57:59.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":10810,"price":77.15,"value":833991.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 26, 2026."}],"balance_after":60073,"source":{"system":"sec-edgar","filing":"0001946439-26-000008","document":"wk-form4_1772492277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000008/wk-form4_1772492277.xml","form_type":"4"}},{"id":888916,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-02-23T22:31:33.000Z","date":"2026-02-20","kind":"sale","planned":true,"acquired":false,"shares":1730,"price":77.99,"value":134922.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in multiple trades at prices ranging from $77.45 to $78.58. The price reported above reflects the weighted average sales price."}],"balance_after":49263,"source":{"system":"sec-edgar","filing":"0001946439-26-000006","document":"wk-form4_1771885891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000006/wk-form4_1771885891.xml","form_type":"4"}},{"id":888915,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-02-23T22:31:33.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":2084,"price":77.53,"value":161572.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025."}],"balance_after":50993,"source":{"system":"sec-edgar","filing":"0001946439-26-000006","document":"wk-form4_1771885891.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000006/wk-form4_1771885891.xml","form_type":"4"}},{"id":902010,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-02-17T21:05:03.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1290,"price":77.36,"value":99794.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,020 shares of restricted stock, the grant of which was previously reported on February 16, 2024."}],"balance_after":53077,"source":{"system":"sec-edgar","filing":"0001946439-26-000004","document":"wk-form4_1771362300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000004/wk-form4_1771362300.xml","form_type":"4"}},{"id":902009,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-02-17T21:05:03.000Z","date":"2026-02-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1180,"price":76.7,"value":90506.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,264 shares of restricted stock, the grant of which was previously reported on February 18, 2025."}],"balance_after":54367,"source":{"system":"sec-edgar","filing":"0001946439-26-000004","document":"wk-form4_1771362300.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000004/wk-form4_1771362300.xml","form_type":"4"}},{"id":905863,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2026-02-13T21:12:43.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":3017,"price":76.25,"value":230046.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,104 performance stock units, the grant of which was previously reported on April 6, 2023."}],"balance_after":55547,"source":{"system":"sec-edgar","filing":"0001946439-26-000002","document":"wk-form4_1771017161.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643926000002/wk-form4_1771017161.xml","form_type":"4"}},{"id":962457,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2025-12-19T21:47:05.000Z","date":"2025-12-18","kind":"sale","planned":true,"acquired":false,"shares":1622,"price":82.4,"value":133652.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2025."}],"balance_after":58564,"source":{"system":"sec-edgar","filing":"0001946439-25-000019","document":"wk-form4_1766180822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643925000019/wk-form4_1766180822.xml","form_type":"4"}},{"id":1035023,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2025-09-22T21:14:59.000Z","date":"2025-09-19","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":98.04,"value":98040.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024."}],"balance_after":60186,"source":{"system":"sec-edgar","filing":"0001946439-25-000017","document":"wk-form4_1758575697.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643925000017/wk-form4_1758575697.xml","form_type":"4"}},{"id":1040899,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2025-09-15T23:17:26.000Z","date":"2025-09-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1710,"price":97.71,"value":167084.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,108 shares of restricted stock, the grant of which was previously reported."}],"balance_after":61186,"source":{"system":"sec-edgar","filing":"0001946439-25-000015","document":"wk-form4_1757978243.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643925000015/wk-form4_1757978243.xml","form_type":"4"}},{"id":1057077,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2025-08-25T20:19:30.000Z","date":"2025-08-22","kind":"sale","planned":false,"acquired":false,"shares":1763,"price":91.1,"value":160609.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple trades at prices ranging from $91.01 to $91.19. The price reported above reflects the weighted average sales price."}],"balance_after":62896,"source":{"system":"sec-edgar","filing":"0001946439-25-000013","document":"wk-form4_1756153167.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643925000013/wk-form4_1756153167.xml","form_type":"4"}},{"id":1196077,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2025-03-20T20:14:00.000Z","date":"2025-03-19","kind":"sale","planned":true,"acquired":false,"shares":1866,"price":65,"value":121290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024."}],"balance_after":64659,"source":{"system":"sec-edgar","filing":"0001946439-25-000010","document":"wk-form4_1742501635.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643925000010/wk-form4_1742501635.xml","form_type":"4"}},{"id":1215835,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2025-03-11T00:28:06.000Z","date":"2025-03-07","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":60.86,"value":60860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024."}],"balance_after":66525,"source":{"system":"sec-edgar","filing":"0001946439-25-000008","document":"wk-form4_1741652880.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643925000008/wk-form4_1741652880.xml","form_type":"4"}},{"id":1231384,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T22:06:10.000Z","date":"2025-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":1099,"price":61.89,"value":68017.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,039 shares of restricted stock, the grant of which was previously reported."}],"balance_after":67525,"source":{"system":"sec-edgar","filing":"0001946439-25-000006","document":"wk-form4_1741125961.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643925000006/wk-form4_1741125961.xml","form_type":"4"}},{"id":1250617,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2025-02-24T21:33:37.000Z","date":"2025-02-21","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":60.2,"value":60200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024."}],"balance_after":68624,"source":{"system":"sec-edgar","filing":"0001946439-25-000004","document":"wk-form4_1740432806.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643925000004/wk-form4_1740432806.xml","form_type":"4"}},{"id":1264813,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2025-02-19T01:13:04.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1196,"price":58.92,"value":70468.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,019 shares of restricted stock, the grant of which was previously reported."}],"balance_after":69624,"source":{"system":"sec-edgar","filing":"0001946439-25-000002","document":"wk-form4_1739927578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643925000002/wk-form4_1739927578.xml","form_type":"4"}},{"id":1264812,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2025-02-19T01:13:04.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":8704,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":70820,"source":{"system":"sec-edgar","filing":"0001946439-25-000002","document":"wk-form4_1739927578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643925000002/wk-form4_1739927578.xml","form_type":"4"}},{"id":1264811,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2025-02-19T01:13:04.000Z","date":"2025-02-12","kind":"grant","planned":false,"acquired":true,"shares":13057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 12, 2025."}],"balance_after":62116,"source":{"system":"sec-edgar","filing":"0001946439-25-000002","document":"wk-form4_1739927578.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643925000002/wk-form4_1739927578.xml","form_type":"4"}},{"id":1334422,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2024-12-12T22:08:37.000Z","date":"2024-12-11","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":60,"value":60000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2024."}],"balance_after":49059,"source":{"system":"sec-edgar","filing":"0001946439-24-000008","document":"wk-form4_1734041311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643924000008/wk-form4_1734041311.xml","form_type":"4"}},{"id":1408012,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2024-09-13T20:23:15.000Z","date":"2024-09-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1486,"price":56.15,"value":83438.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,108 shares of restricted stock, the grant of which was previously reported."}],"balance_after":50059,"source":{"system":"sec-edgar","filing":"0001946439-24-000006","document":"wk-form4_1726258989.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643924000006/wk-form4_1726258989.xml","form_type":"4"}},{"id":1608048,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2024-03-01T21:59:50.000Z","date":"2024-02-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":1173,"price":67.67,"value":79376.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,039 shares of restricted stock, the grant of which was previously reported."}],"balance_after":51545,"source":{"system":"sec-edgar","filing":"0001946439-24-000004","document":"wk-form4_1709330377.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643924000004/wk-form4_1709330377.xml","form_type":"4"}},{"id":1639205,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2024-02-16T21:30:42.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":8052,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":52718,"source":{"system":"sec-edgar","filing":"0001946439-24-000002","document":"wk-form4_1708119020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643924000002/wk-form4_1708119020.xml","form_type":"4"}},{"id":1639204,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2024-02-16T21:30:42.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":12079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 14, 2024."}],"balance_after":44666,"source":{"system":"sec-edgar","filing":"0001946439-24-000002","document":"wk-form4_1708119020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643924000002/wk-form4_1708119020.xml","form_type":"4"}},{"id":1739618,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2023-11-16T23:13:34.000Z","date":"2023-11-15","kind":"sale","planned":false,"acquired":false,"shares":2622,"price":53.81,"value":141089.82,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $53.80 to $53.91, inclusive."}],"balance_after":32587,"source":{"system":"sec-edgar","filing":"0001946439-23-000005","document":"wk-form4_1700176406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643923000005/wk-form4_1700176406.xml","form_type":"4"}},{"id":1781294,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2023-09-14T12:01:59.000Z","date":"2023-09-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":1486,"price":61.91,"value":91998.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,108 shares of restricted stock, the grant of which was previously reported."}],"balance_after":35209,"source":{"system":"sec-edgar","filing":"0001946439-23-000003","document":"wk-form4_1694692910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000194643923000003/wk-form4_1694692910.xml","form_type":"4"}},{"id":1929759,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2023-04-05T00:01:21.000Z","date":"2023-02-28","kind":"grant","planned":false,"acquired":true,"shares":8104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These shares represent performance stock units, which will vest over the applicable performance period based on the achievement of the provided performance targets, as set forth in the governing award agreement, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting."}],"balance_after":36695,"source":{"system":"sec-edgar","filing":"0001104659-23-041721","document":"tm2311710-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923041721/tm2311710-3_4seq1.xml","form_type":"4"}},{"id":1929758,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2023-04-05T00:01:21.000Z","date":"2023-02-28","kind":"grant","planned":false,"acquired":true,"shares":12158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of February 28, 2023."}],"balance_after":28591,"source":{"system":"sec-edgar","filing":"0001104659-23-041721","document":"tm2311710-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000110465923041721/tm2311710-3_4seq1.xml","form_type":"4"}},{"id":2159610,"issuer":{"id":4638,"kind":"organization","name":"ANI PHARMACEUTICALS INC","symbol":"ANIP"},"owners":[{"id":61838,"kind":"person","name":"Davis Krista","position":1,"cik":"0001946439","reported_name":"Davis Krista","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, CHIEF HR OFFICER"}}],"security":"Common Stock","published_at":"2022-09-14T23:06:01.000Z","date":"2022-09-12","kind":"grant","acquired":true,"shares":16433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a restricted stock award that will vest in four equal annual installments on the first, second, third and fourth anniversaries of September 12, 2022."}],"balance_after":16433,"source":{"system":"sec-edgar","filing":"0001415889-22-009623","document":"form4-09142022_040950.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1023024/000141588922009623/form4-09142022_040950.xml","form_type":"4"}}]}